Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018
It has been almost a decade since the commentary by Gaze and Flux (2010) . The overarching feeling then was that no individual or organisation has taken up the challenge, nationally or internationally, of championing molecular targeted radionuclide therapy in all its aspects. Here, we report on the...
Gespeichert in:
| Veröffentlicht in: | British journal of radiology 2019-08, Vol.92 (1100), p.20190117-20190117 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 20190117 |
|---|---|
| container_issue | 1100 |
| container_start_page | 20190117 |
| container_title | British journal of radiology |
| container_volume | 92 |
| creator | Falzone, Nadia Gregory, Rebecca Aldridge, Matthew Terry, Samantha Ya Flux, Glenn |
| description | It has been almost a decade since the commentary
by Gaze and Flux (2010) . The overarching feeling then was that no individual or organisation has taken up the challenge, nationally or internationally, of championing molecular targeted radionuclide therapy in all its aspects. Here, we report on the recent NCRI-CTRad (Clinical Trials in Molecular Radiotherapy-Tribulations and Triumphs) meeting, held in London on the 8 June 2018. The meeting was organized by the NCRI-CTRad to review the challenges and opportunities for clinical trials in molecular radiotherapy, particularly focussing on investigator-led trials that incorporate imaging and dosimetry, and to discuss how the community can move forward. This meeting was organised in conjunction with the British Nuclear Medicine Society and reflects the progress of Nuclear Medicine in the UK. |
| doi_str_mv | 10.1259/bjr.20190117 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6724631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2210007926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-52af736348f0c5b132ea1aeb47c99dcbf3c1bad52296dc5dfe775a2199832a0a3</originalsourceid><addsrcrecordid>eNpVkclqHDEQhkWIicd2bjkHHXNwO1p6kS6B0GSZMNgwTCA3Ua1Wz8h0Sx1JbfA75KGj8UZyKqrq46_lR-gdJVeUVfJjdxuuGKGSUNq8QivalKIQgvx6jVaEkKagTFSn6CzG22NaSfIGnXIiBeNluUJ_2tE6q2HEKVgYI7YOT340ehkh4AC99elgAsz3xS7YLleT9S5icD3OhWWaDxFvzexDwn7AmcXX7XaN290WejwZk6zb44MZewzpob2xQ8LrmMfuk3eXWOAfizM4nyAu0MmQdzBvn-I5-vn1y679Xmxuvq3bz5tCc1GmomIwNLzmpRiIrjrKmQEKpisbLWWvu4Fr2kFfMSbrXlf9YJqmAkalFJwBAX6OPj3qzks3mV4blwKMag52gnCvPFj1f8fZg9r7O1U3rKw5zQIfngSC_72YmNRkozbjCM74JSrG6PHZktUZvXxEdfAxBjO8jKFEHQ1U2UD1bGDG3_-72gv87Bj_C5YDmHo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2210007926</pqid></control><display><type>article</type><title>Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Falzone, Nadia ; Gregory, Rebecca ; Aldridge, Matthew ; Terry, Samantha Ya ; Flux, Glenn</creator><creatorcontrib>Falzone, Nadia ; Gregory, Rebecca ; Aldridge, Matthew ; Terry, Samantha Ya ; Flux, Glenn</creatorcontrib><description>It has been almost a decade since the commentary
by Gaze and Flux (2010) . The overarching feeling then was that no individual or organisation has taken up the challenge, nationally or internationally, of championing molecular targeted radionuclide therapy in all its aspects. Here, we report on the recent NCRI-CTRad (Clinical Trials in Molecular Radiotherapy-Tribulations and Triumphs) meeting, held in London on the 8 June 2018. The meeting was organized by the NCRI-CTRad to review the challenges and opportunities for clinical trials in molecular radiotherapy, particularly focussing on investigator-led trials that incorporate imaging and dosimetry, and to discuss how the community can move forward. This meeting was organised in conjunction with the British Nuclear Medicine Society and reflects the progress of Nuclear Medicine in the UK.</description><identifier>ISSN: 0007-1285</identifier><identifier>EISSN: 1748-880X</identifier><identifier>DOI: 10.1259/bjr.20190117</identifier><identifier>PMID: 30982344</identifier><language>eng</language><publisher>England: The British Institute of Radiology</publisher><ispartof>British journal of radiology, 2019-08, Vol.92 (1100), p.20190117-20190117</ispartof><rights>2019 The Authors. Published by the British Institute of Radiology 2019 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-52af736348f0c5b132ea1aeb47c99dcbf3c1bad52296dc5dfe775a2199832a0a3</citedby><cites>FETCH-LOGICAL-c384t-52af736348f0c5b132ea1aeb47c99dcbf3c1bad52296dc5dfe775a2199832a0a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30982344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Falzone, Nadia</creatorcontrib><creatorcontrib>Gregory, Rebecca</creatorcontrib><creatorcontrib>Aldridge, Matthew</creatorcontrib><creatorcontrib>Terry, Samantha Ya</creatorcontrib><creatorcontrib>Flux, Glenn</creatorcontrib><title>Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018</title><title>British journal of radiology</title><addtitle>Br J Radiol</addtitle><description>It has been almost a decade since the commentary
by Gaze and Flux (2010) . The overarching feeling then was that no individual or organisation has taken up the challenge, nationally or internationally, of championing molecular targeted radionuclide therapy in all its aspects. Here, we report on the recent NCRI-CTRad (Clinical Trials in Molecular Radiotherapy-Tribulations and Triumphs) meeting, held in London on the 8 June 2018. The meeting was organized by the NCRI-CTRad to review the challenges and opportunities for clinical trials in molecular radiotherapy, particularly focussing on investigator-led trials that incorporate imaging and dosimetry, and to discuss how the community can move forward. This meeting was organised in conjunction with the British Nuclear Medicine Society and reflects the progress of Nuclear Medicine in the UK.</description><issn>0007-1285</issn><issn>1748-880X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpVkclqHDEQhkWIicd2bjkHHXNwO1p6kS6B0GSZMNgwTCA3Ua1Wz8h0Sx1JbfA75KGj8UZyKqrq46_lR-gdJVeUVfJjdxuuGKGSUNq8QivalKIQgvx6jVaEkKagTFSn6CzG22NaSfIGnXIiBeNluUJ_2tE6q2HEKVgYI7YOT340ehkh4AC99elgAsz3xS7YLleT9S5icD3OhWWaDxFvzexDwn7AmcXX7XaN290WejwZk6zb44MZewzpob2xQ8LrmMfuk3eXWOAfizM4nyAu0MmQdzBvn-I5-vn1y679Xmxuvq3bz5tCc1GmomIwNLzmpRiIrjrKmQEKpisbLWWvu4Fr2kFfMSbrXlf9YJqmAkalFJwBAX6OPj3qzks3mV4blwKMag52gnCvPFj1f8fZg9r7O1U3rKw5zQIfngSC_72YmNRkozbjCM74JSrG6PHZktUZvXxEdfAxBjO8jKFEHQ1U2UD1bGDG3_-72gv87Bj_C5YDmHo</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Falzone, Nadia</creator><creator>Gregory, Rebecca</creator><creator>Aldridge, Matthew</creator><creator>Terry, Samantha Ya</creator><creator>Flux, Glenn</creator><general>The British Institute of Radiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190801</creationdate><title>Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018</title><author>Falzone, Nadia ; Gregory, Rebecca ; Aldridge, Matthew ; Terry, Samantha Ya ; Flux, Glenn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-52af736348f0c5b132ea1aeb47c99dcbf3c1bad52296dc5dfe775a2199832a0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Falzone, Nadia</creatorcontrib><creatorcontrib>Gregory, Rebecca</creatorcontrib><creatorcontrib>Aldridge, Matthew</creatorcontrib><creatorcontrib>Terry, Samantha Ya</creatorcontrib><creatorcontrib>Flux, Glenn</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Falzone, Nadia</au><au>Gregory, Rebecca</au><au>Aldridge, Matthew</au><au>Terry, Samantha Ya</au><au>Flux, Glenn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018</atitle><jtitle>British journal of radiology</jtitle><addtitle>Br J Radiol</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>92</volume><issue>1100</issue><spage>20190117</spage><epage>20190117</epage><pages>20190117-20190117</pages><issn>0007-1285</issn><eissn>1748-880X</eissn><abstract>It has been almost a decade since the commentary
by Gaze and Flux (2010) . The overarching feeling then was that no individual or organisation has taken up the challenge, nationally or internationally, of championing molecular targeted radionuclide therapy in all its aspects. Here, we report on the recent NCRI-CTRad (Clinical Trials in Molecular Radiotherapy-Tribulations and Triumphs) meeting, held in London on the 8 June 2018. The meeting was organized by the NCRI-CTRad to review the challenges and opportunities for clinical trials in molecular radiotherapy, particularly focussing on investigator-led trials that incorporate imaging and dosimetry, and to discuss how the community can move forward. This meeting was organised in conjunction with the British Nuclear Medicine Society and reflects the progress of Nuclear Medicine in the UK.</abstract><cop>England</cop><pub>The British Institute of Radiology</pub><pmid>30982344</pmid><doi>10.1259/bjr.20190117</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1285 |
| ispartof | British journal of radiology, 2019-08, Vol.92 (1100), p.20190117-20190117 |
| issn | 0007-1285 1748-880X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6724631 |
| source | Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| title | Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A10%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20trials%20in%20molecular%20radiotherapy-Tribulations%20and%20Triumphs%20Report%20of%20the%20NCRI%20CTRad%20meeting%20held%20at%20the%20Lift%20Islington,%208%20June%202018&rft.jtitle=British%20journal%20of%20radiology&rft.au=Falzone,%20Nadia&rft.date=2019-08-01&rft.volume=92&rft.issue=1100&rft.spage=20190117&rft.epage=20190117&rft.pages=20190117-20190117&rft.issn=0007-1285&rft.eissn=1748-880X&rft_id=info:doi/10.1259/bjr.20190117&rft_dat=%3Cproquest_pubme%3E2210007926%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2210007926&rft_id=info:pmid/30982344&rfr_iscdi=true |